中国实用妇科与产科杂志

• 专题笔谈 • 上一篇    下一篇

新辅助化疗治疗晚期子宫内膜癌疗效分析

刘婵桢张洁清李力   

  1. 作者单位:广西医科大学附属肿瘤医院妇瘤科,广西 南宁 530021
  • 出版日期:2016-09-02 发布日期:2016-09-06
  • 通讯作者: 李力

Efficacy of neoadjuvant chemotherapy in the treatment of advanced endometrial carcinoma.

LIU Chan-zhen, ZHANG Jie-qing,LI Li.   

  1. Department of Gynecologic Oncology,Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, China
  • Online:2016-09-02 Published:2016-09-06

摘要:

晚期子宫内膜癌初次手术治疗难以切除干净,预后差。化疗是晚期子宫内膜癌主要治疗方式,新辅助化疗在晚期子宫内膜癌中的作用已引起重视。文章对新辅助化疗的疗效、方案、途径进行分析总结,为晚期子宫内膜癌合理治疗提供依据。

关键词: 子宫内膜肿瘤, 新辅助化疗, 抗肿瘤联合化疗方案

Abstract:

Abstract: Advanced endometrial carcinoma is difficult to be managed successfully in primary cytoreductive surgery, and its prognosis is poor.Chemotherapy is the main treatment for advanced endometrial carcinoma .The role of chemotherapy in advanced endometrial carcinoma is currently the focus of the researchers.This review analyzes and summarizes the efficacy and regimens of neoadjuvant chemotherapy so that rational treatment strategies can be made.

中图分类号: